Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.

Cell Lines as Biological Models: Practical Steps for More Reliable Research.

Capes-Davis A, Bairoch A, Barrett T, Burnett EC, Dirks WG, Hall EM, Healy L, Kniss DA, Korch C, Liu Y, Neve RM, Nims RW, Parodi B, Schweppe RE, Storts DR, Tian F.

Chem Res Toxicol. 2019 Sep 16;32(9):1733-1736. doi: 10.1021/acs.chemrestox.9b00215. Epub 2019 Jun 15.

PMID:
31203605
2.

Effectiveness of Dettol Antiseptic Liquid for Inactivation of Ebola Virus in Suspension.

Cutts TA, Ijaz MK, Nims RW, Rubino JR, Theriault SS.

Sci Rep. 2019 Apr 29;9(1):6590. doi: 10.1038/s41598-019-42386-5.

3.

Assessment of a respiratory face mask for capturing air pollutants and pathogens including human influenza and rhinoviruses.

Zhou SS, Lukula S, Chiossone C, Nims RW, Suchmann DB, Ijaz MK.

J Thorac Dis. 2018 Mar;10(3):2059-2069. doi: 10.21037/jtd.2018.03.103. Erratum in: J Thorac Dis. 2018 Aug;10(8):E676-E677.

4.

Best practices for authenticating cell lines.

Nims RW, Reid Y.

In Vitro Cell Dev Biol Anim. 2017 Dec;53(10):880-887. doi: 10.1007/s11626-017-0212-8. Epub 2017 Dec 1. Review.

PMID:
29197028
5.

Best practices for detecting and mitigating the risk of cell culture contaminants.

Nims RW, Price PJ.

In Vitro Cell Dev Biol Anim. 2017 Dec;53(10):872-879. doi: 10.1007/s11626-017-0203-9. Epub 2017 Dec 1. Review.

PMID:
29197027
6.

Authentication of M14 melanoma cell line proves misidentification of MDA-MB-435 breast cancer cell line.

Korch C, Hall EM, Dirks WG, Ewing M, Faries M, Varella-Garcia M, Robinson S, Storts D, Turner JA, Wang Y, Burnett EC, Healy L, Kniss D, Neve RM, Nims RW, Reid YA, Robinson WA, Capes-Davis A.

Int J Cancer. 2018 Feb 1;142(3):561-572. doi: 10.1002/ijc.31067. Epub 2017 Oct 10.

7.

Best practices in cell culture: an overview.

Baust JM, Buehring GC, Campbell L, Elmore E, Harbell JW, Nims RW, Price P, Reid YA, Simione F.

In Vitro Cell Dev Biol Anim. 2017 Sep;53(8):669-672. doi: 10.1007/s11626-017-0177-7. Epub 2017 Aug 14. Review.

PMID:
28808859
8.

Best practices for the use and evaluation of animal serum as a component of cell culture medium.

Nims RW, Harbell JW.

In Vitro Cell Dev Biol Anim. 2017 Sep;53(8):682-690. doi: 10.1007/s11626-017-0184-8. Epub 2017 Jul 21.

PMID:
28733930
9.

Intra-family differences in efficacy of inactivation of small, non-enveloped viruses.

Nims RW, Zhou SS.

Biologicals. 2016 Sep;44(5):456-62. doi: 10.1016/j.biologicals.2016.05.005. Epub 2016 Jul 26. Review.

PMID:
27473770
10.

Beware imposters: MA-1, a novel MALT lymphoma cell line, is misidentified and corresponds to Pfeiffer, a diffuse large B-cell lymphoma cell line.

Capes-Davis A, Alston-Roberts C, Kerrigan L, Reid YA, Barrett T, Burnett EC, Cooper JR, Freshney RI, Healy L, Kohara A, Korch C, Masters JR, Nakamura Y, Nims RW, Storts DR, Dirks WG, MacLeod RA, Drexler HG.

Genes Chromosomes Cancer. 2013 Oct;52(10):986-8. doi: 10.1002/gcc.22094. Epub 2013 Aug 1. No abstract available.

PMID:
23907998
11.

Match criteria for human cell line authentication: where do we draw the line?

Capes-Davis A, Reid YA, Kline MC, Storts DR, Strauss E, Dirks WG, Drexler HG, MacLeod RA, Sykes G, Kohara A, Nakamura Y, Elmore E, Nims RW, Alston-Roberts C, Barallon R, Los GV, Nardone RM, Price PJ, Steuer A, Thomson J, Masters JR, Kerrigan L.

Int J Cancer. 2013 Jun 1;132(11):2510-9. doi: 10.1002/ijc.27931. Epub 2012 Nov 28.

12.

Polyomavirus inactivation - a review.

Nims RW, Plavsic M.

Biologicals. 2013 Mar;41(2):63-70. doi: 10.1016/j.biologicals.2012.09.011. Epub 2012 Oct 30. Review.

PMID:
23116715
13.

Gamma irradiation of animal sera for inactivation of viruses and mollicutes--a review.

Nims RW, Gauvin G, Plavsic M.

Biologicals. 2011 Nov;39(6):370-7. doi: 10.1016/j.biologicals.2011.05.003. Epub 2011 Aug 25. Review.

PMID:
21871817
14.

Authentication of human cell-based products: the role of a new consensus standard.

Kerrigan L, Nims RW.

Regen Med. 2011 Mar;6(2):255-60. doi: 10.2217/rme.11.5. Review.

PMID:
21391858
15.

Short tandem repeat profiling: part of an overall strategy for reducing the frequency of cell misidentification.

Nims RW, Sykes G, Cottrill K, Ikonomi P, Elmore E.

In Vitro Cell Dev Biol Anim. 2010 Dec;46(10):811-9. doi: 10.1007/s11626-010-9352-9. Epub 2010 Oct 7. Review.

16.

Recommendation of short tandem repeat profiling for authenticating human cell lines, stem cells, and tissues.

Barallon R, Bauer SR, Butler J, Capes-Davis A, Dirks WG, Elmore E, Furtado M, Kline MC, Kohara A, Los GV, MacLeod RA, Masters JR, Nardone M, Nardone RM, Nims RW, Price PJ, Reid YA, Shewale J, Sykes G, Steuer AF, Storts DR, Thomson J, Taraporewala Z, Alston-Roberts C, Kerrigan L.

In Vitro Cell Dev Biol Anim. 2010 Oct;46(9):727-32. doi: 10.1007/s11626-010-9333-z. Epub 2010 Jul 8.

17.

Use of the cytosensor microphysiometer to predict results of a 21-day cumulative irritation patch test in humans.

Landin WE, Mun GC, Nims RW, Harbell JW.

Toxicol In Vitro. 2007 Sep;21(6):1165-73. Epub 2007 Mar 23.

PMID:
17475442
18.

Detection of adventitious viruses in biologicals--a rare occurrence.

Nims RW.

Dev Biol (Basel). 2006;123:153-64; discussion 183-97.

PMID:
16566443
19.

Metabolism of a liver-selective nitric oxide-releasing agent, V-PYRRO/NO, by human microsomal cytochromes P450.

Inami K, Nims RW, Srinivasan A, Citro ML, Saavedra JE, Cederbaum AI, Keefer LK.

Nitric Oxide. 2006 Jun;14(4):309-15. Epub 2006 Mar 20.

PMID:
16545970
20.

Comparison of the reactivity of nitric oxide and nitroxyl with heme proteins. A chemical discussion of the differential biological effects of these redox related products of NOS.

Miranda KM, Nims RW, Thomas DD, Espey MG, Citrin D, Bartberger MD, Paolocci N, Fukuto JM, Feelisch M, Wink DA.

J Inorg Biochem. 2003 Jan 1;93(1-2):52-60.

PMID:
12538052
21.

Plasma pharmacokinetics of a liver-selective nitric oxide-donating diazeniumdiolate in the male C57BL/6 mouse.

Stinson SF, House T, Bramhall C, Saavedra JE, Keefer LK, Nims RW.

Xenobiotica. 2002 Apr;32(4):339-47.

PMID:
12028666
22.
23.

Cytochrome P450 induction in feral Cricetid rodents: a review of field and laboratory investigations.

Qualls CW Jr, Lubet RA, Lochmiller RL, Elangbam CS, Lish JW, Nims RW.

Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 1998 Nov;121(1-3):55-63. Review.

PMID:
9972450
24.

Dose-response relationships for cytochrome P450 induction by phenobarbital in the cotton rat (Sigmodon hispidus).

Jones CR, Lubet RA, Henneman JR, Nims RW.

Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 1998 Nov;121(1-3):197-203.

PMID:
9972461
25.
26.

Sensitivity of isoenzyme analysis for the detection of interspecies cell line cross-contamination.

Nims RW, Shoemaker AP, Bauernschub MA, Rec LJ, Harbell JW.

In Vitro Cell Dev Biol Anim. 1998 Jan;34(1):35-9.

PMID:
9542633
27.

Comparative pharmacodynamics of CYP2B induction by DDT, DDE, and DDD in male rat liver and cultured rat hepatocytes.

Nims RW, Lubet RA, Fox SD, Jones CR, Thomas PE, Reddy AB, Kocarek TA.

J Toxicol Environ Health A. 1998 Mar 27;53(6):455-77.

PMID:
9537282
28.

TGF-alpha sustains clonal expansion by promoter-dependent, chemically initiated rat hepatocytes.

Kaufmann WK, Byrd LL, Palmieri D, Nims RW, Rice JM.

Carcinogenesis. 1997 Jul;18(7):1381-7.

PMID:
9230284
29.

In vivo induction and in vitro inhibition of hepatic cytochrome P450 activity by the benzodiazepine anticonvulsants clonazepam and diazepam.

Nims RW, Prough RA, Jones CR, Stockus DL, Dragnev KH, Thomas PE, Lubet RA.

Drug Metab Dispos. 1997 Jun;25(6):750-6.

PMID:
9193878
30.

Regulation of gene expression of various phase I and phase II drug-metabolizing enzymes by tamoxifen in rat liver.

Hellriegel ET, Matwyshyn GA, Fei P, Dragnev KH, Nims RW, Lubet RA, Kong AN.

Biochem Pharmacol. 1996 Nov 22;52(10):1561-8.

PMID:
8937471
31.

Convenient colorimetric and fluorometric assays for S-nitrosothiols.

Cook JA, Kim SY, Teague D, Krishna MC, Pacelli R, Mitchell JB, Vodovotz Y, Nims RW, Christodoulou D, Miles AM, Grisham MB, Wink DA.

Anal Biochem. 1996 Jul 1;238(2):150-8.

PMID:
8660604
32.

"NONOates" (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms.

Keefer LK, Nims RW, Davies KM, Wink DA.

Methods Enzymol. 1996;268:281-93. No abstract available.

PMID:
8782594
33.

Determination of selectivity of reactive nitrogen oxide species for various substrates.

Wink DA, Grisham MB, Miles AM, Nims RW, Krishna MC, Pacelli R, Teague D, Poore CM, Cook JA, Ford PC.

Methods Enzymol. 1996;268:120-30. No abstract available.

PMID:
8782578
34.

Colorimetric assays for nitric oxide and nitrogen oxide species formed from nitric oxide stock solutions and donor compounds.

Nims RW, Cook JC, Krishna MC, Christodoulou D, Poore CM, Miles AM, Grisham MB, Wink DA.

Methods Enzymol. 1996;268:93-105. No abstract available.

PMID:
8782576
35.

Chemical biology of nitric oxide: regulation and protective and toxic mechanisms.

Wink DA, Hanbauer I, Grisham MB, Laval F, Nims RW, Laval J, Cook J, Pacelli R, Liebmann J, Krishna M, Ford PC, Mitchell JB.

Curr Top Cell Regul. 1996;34:159-87. Review. No abstract available.

PMID:
8646847
36.
37.

The chemopreventive agent diallyl sulfide. A structurally atypical phenobarbital-type inducer.

Dragnev KH, Nims RW, Lubet RA.

Biochem Pharmacol. 1995 Dec 22;50(12):2099-104.

PMID:
8849338
38.
39.

Relative potencies of induction of hepatic drug-metabolizing enzyme genes by individual PCB congeners.

Dragnev KH, Nims RW, Fox SD, Lindahl R, Lubet RA.

Toxicol Appl Pharmacol. 1995 Jun;132(2):334-42.

PMID:
7785061
40.

Direct measurement of the accumulation and mitochondrial conversion of nitric oxide within Chinese hamster ovary cells using an intracellular electron paramagnetic resonance technique.

Clarkson RB, Norby SW, Smirnov A, Boyer S, Vahidi N, Nims RW, Wink DA.

Biochim Biophys Acta. 1995 Apr 13;1243(3):496-502.

PMID:
7727525
41.

Absence of enantioselectivity in the pharmacodynamics of P450 2B induction by 5-ethyl-5-phenylhydantoin in the male rat liver or in cultured rat hepatocytes.

Nims RW, Sidhu JS, Thomas PE, Mellini DW, Nelson VC, Omiecinski CJ, Lubet RA.

J Biochem Toxicol. 1994 Dec;9(6):279-88.

PMID:
7534352
42.
43.

Hepatic cytochrome P450 2B induction by ethyl/phenyl-substituted congeners of phenobarbital in the B6C3F1 mouse.

Nims RW, Lubet RA, Diwan BA, Mellini DW, Utermahlen WE Jr, Thomas PE.

J Biochem Toxicol. 1994 Oct;9(5):269-78.

PMID:
7853362
44.

Oxidizing intermediates generated in the Fenton reagent: kinetic arguments against the intermediacy of the hydroxyl radical.

Wink DA, Wink CB, Nims RW, Ford PC.

Environ Health Perspect. 1994 Sep;102 Suppl 3:11-5. Review.

45.
46.

Comparative pharmacodynamics of hepatic cytochrome P450 2B induction by 5,5-diphenyl- and 5,5-diethyl-substituted barbiturates and hydantoins in the male F344/NCr rat.

Nims RW, McClain RM, Manchand PS, Belica PS, Thomas PE, Mellini DW, Utermahlen WE Jr, Lubet RA.

J Pharmacol Exp Ther. 1994 Jul;270(1):348-55.

PMID:
8035330
47.

Reaction kinetics for nitrosation of cysteine and glutathione in aerobic nitric oxide solutions at neutral pH. Insights into the fate and physiological effects of intermediates generated in the NO/O2 reaction.

Wink DA, Nims RW, Darbyshire JF, Christodoulou D, Hanbauer I, Cox GW, Laval F, Laval J, Cook JA, Krishna MC, et al.

Chem Res Toxicol. 1994 Jul-Aug;7(4):519-25.

PMID:
7981416
48.

Induction of cytochrome P-450 in Sigmodon hispidus (cotton rats) exposed to dietary Aroclor 1254.

Henneman JR, Fox SD, Lubet RA, Ward JM, Nims RW.

J Toxicol Environ Health. 1994 Mar;41(3):369-86.

PMID:
8126756
49.

Supplemental Content

Support Center